Literature DB >> 16904822

RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis.

Shengzhen Guo1, Wei Tang, Yongyong Shi, Ke Huang, Zhengrui Xi, Yifeng Xu, Guoying Feng, Lin He.   

Abstract

Recently, several researches based on expression analysis, genetic linkage and association studies have suggested that the regulator of G-protein signaling 4 (RGS4) might be a schizophrenia susceptibility gene. However, these linkage and association studies have been conducted using different ethnic samples, and have therefore tended to produce inconsistent results. To help to clarify this inconsistency, we used non-family based samples to carry out a case-control analysis on six single nucleotide polymorphisms (SNPs) (including four widely investigated SNPs, SNP1, 4, 7, 18 and another two SNPs, rs2842030 and rs2344671) in a Chinese Han sample set comprising 288 schizophrenia patients and 288 normal controls. All genotypings were conducted by direct sequencing and all SNPs were in Hardy-Weinberg equilibrium. We found no individual SNPs or haplotypes to be associated with schizophrenia. We also performed a meta-analysis based on all published population-based association studies on the topic including our own. The results of both our case-control study in the Chinese Han population and the meta-analysis yield no significant evidence for association, which suggests that the genetic polymorphisms within RGS4 are unlikely to confer an increased susceptibility to the etiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904822     DOI: 10.1016/j.neulet.2006.07.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

2.  Association between RGS4 variants and psychotic-like experiences in nonclinical individuals.

Authors:  Marta de Castro-Catala; Paula Cristóbal-Narváez; Thomas R Kwapil; Tamara Sheinbaum; Elionora Peña; Neus Barrantes-Vidal; Araceli Rosa
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-02-24       Impact factor: 5.270

Review 3.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 4.  Analyzing schizophrenia by DNA microarrays.

Authors:  Szatmár Horváth; Zoltán Janka; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2011-01-15       Impact factor: 13.382

Review 5.  Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Authors:  Noah L Lazar; Richard W J Neufeld; Donald P Cain
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

6.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

7.  RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.

Authors:  Konasale M Prasad; Laura Almasy; Ruben C Gur; Raquel E Gur; Michael Pogue-Geile; Kodavali V Chowdari; Michael E Talkowski; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-12       Impact factor: 9.306

8.  Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle.

Authors:  Fang Li; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Gene       Date:  2009-11-26       Impact factor: 3.688

9.  Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil Bamne; Joel Wood; Michael E Talkowski; Karoly Mirnics; Pat Levitt; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-05-21       Impact factor: 9.306

10.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Authors:  M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis
Journal:  Mol Psychiatry       Date:  2008-12-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.